Shining a light on thyroid eye disease

Ludgate, Marian 2020. Shining a light on thyroid eye disease. Nature Reviews Endocrinology 16 , pp. 259-260. 10.1038/s41574-020-0340-1

Preview

PDF - Accepted Post-Print Version Download (1MB) | Preview

Abstract

Effective medical treatment for thyroid eye disease, a debilitating condition which may cause sight-loss, has been lacking. A recent phase III trial of Teprotumumab, an IGF1R antagonist, reports most encouraging results – may be a game-changer? The trial is put in the context of current management strategies to address this question.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	Nature Publishing Group
ISSN:	1759-5029
Date of First Compliant Deposit:	6 March 2020
Date of Acceptance:	28 February 2020
Last Modified:	16 Nov 2024 16:30
URI:	https://orca.cardiff.ac.uk/id/eprint/130175

Citation Data

Cited 2 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item